GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.120
-0.170 (-3.96%)
At close: Apr 4, 2025, 4:00 PM
4.121
+0.001 (0.03%)
After-hours: Apr 4, 2025, 7:56 PM EDT
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $1.58 billion as of April 4, 2025. Its market cap has decreased by -41.16% in one year.
Market Cap
1.58B
Enterprise Value
1.68B
1-Year Change
-41.16%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $1.58B, a decrease of -87.53%. That is a compound annual growth rate of -36.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 4, 2025 | 1.58B | -11.67% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.90B |
| UnitedHealth Group | 480.27B |
| Johnson & Johnson | 369.29B |
| AbbVie | 330.73B |
| Novo Nordisk | 282.33B |
| AstraZeneca | 216.62B |
| Abbott Laboratories | 215.82B |
| Merck & Co. | 205.80B |